Insights into the impact of microbiota in the treatment of nafld/nash and its potential as a biomarker for prognosis and diagnosis

Loading...
Thumbnail Image

Document type

journal article

Collections

Total downloads53
Total views7
Bibliographic managers

Publisher

MDPI AG

Citation

Biomedicines, 9(2), 1-21. https://doi.org/10.3390/biomedicines9020145

Abstract

Non-alcoholic fatty liver disease (NAFLD) is an increasing cause of chronic liver illness associated with obesity and metabolic disorders, such as hypertension, dyslipidemia, or type 2 diabetes mellit...

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Except where otherwised noted, this item's license is described as Creative Commons Attribution 4.0 International
Usage statistics
01345
May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26